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Proteinuria precedes podocyte abnormalities
in Lamb2–/– mice, implicating the glomerular
basement membrane as an albumin barrier
George Jarad,1 Jeanette Cunningham,1 Andrey S. Shaw,2 and Jeffrey H. Miner1
1Renal

Division, Department of Internal Medicine, and 2Department of Pathology and Immunology,
Washington University School of Medicine, St. Louis, Missouri, USA.

Primary defects in either podocytes or the glomerular basement membrane (GBM) cause proteinuria, a fact
that complicates defining the barrier to albumin. Laminin β2 (LAMB2) is a GBM component required for
proper functioning of the glomerular filtration barrier. To investigate the GBM’s role in glomerular filtration, we characterized GBM and overlying podocyte architecture in relation to development and progression
of proteinuria in Lamb2–/– mice, which model Pierson syndrome, a rare congenital nephrotic syndrome. We
found ectopic deposition of several laminins and mislocalization of anionic sites in the GBM, which together
suggest that the Lamb2–/– GBM is severely disorganized, although it is ultrastructurally intact. Importantly,
albuminuria was detectable shortly after birth and preceded podocyte foot process effacement and loss of slit
diaphragms by at least 7 days. Expression and localization of slit diaphragm and foot process–associated proteins appeared normal at early stages. GBM permeability to the electron-dense tracer ferritin was dramatically
elevated in Lamb2–/– mice, even before widespread foot process effacement. Increased ferritin permeability was
not observed in nephrotic CD2-associated protein–null (Cd2ap–/–) mice, which have a primary podocyte defect.
Together these data show that the GBM serves as a barrier to protein in vivo and that the glomerular slit diaphragm alone is not sufficient to prevent the passage of albumin into the urinary space.
Introduction
Laminins are heterotrimeric basement membrane (BM) glycoproteins consisting of α, β, and γ chains. In mammals there are 5 α,
4 β, and 3 γ chains that assemble to form at least 15 heterotrimers
(1). Laminins provide the basic scaffold for assembly of other BM
components, including type IV collagen, nidogen/entactin, and
sulfated proteoglycans (2). BMs are the thin sheets of extracellular
matrix adjacent to many cell types, including most epithelia and
endothelia. Their importance extends beyond merely providing
mechanical support for cells; BMs are critical for cell proliferation,
differentiation, survival, and function, as has been clearly shown in
human diseases or animal models with BM abnormalities (1, 3).
The kidney glomerular BM (GBM) is an unusually thick BM
formed via fusion of distinct BMs assembled by glomerular epithelial cells (podocytes) and glomerular endothelial cells (4). The
GBM is functionally unique; it must facilitate constant fluid
flow across the glomerular filtration barrier (GFB) — consisting
of endothelium, GBM, and podocyte — while tolerating hemodynamic stresses and providing support for glomerular cells.
The composition of the GBM is also specialized, as it is the only
nephron-associated BM in the kidney whose laminin composition is exclusively laminin α5β2γ1, referred to as LM-521 in the
new nomenclature (3, 5).
Whereas the α5 chain, as part of LM-511 (α5β1γ1) and LM521, is required for GBM integrity and glomerular vascularNonstandard abbreviations used: Cd2ap–/–, CD2-associated protein–null; BM,
basement membrane; FP, foot process; GBM, glomerular BM; GFB, glomerular filtration barrier; Lamb2–/–, laminin b2–null; SD, slit diaphragm; SEM, scanning electron
microscopy; TEM, transmission electron microscopy.
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ization (6), the β2 chain is dispensable for glomerulogenesis.
Laminin β2–null (Lamb2–/–) mice are born alive overtly indistinguishable from normal littermates (7, 8). GBM ultrastructure
appears essentially normal, because LM-511, normally found
in immature GBM, compensates structurally for the missing
LM-521 in mature GBM (8). Lamb2–/– mice develop severe neuromuscular defects and nephrotic syndrome with progressive
foot process (FP) effacement. Mutant mice fail to thrive; they
stop gaining weight at P7 and die at approximately P21 due
primarily to the neuromuscular defects (9). The mouse Lamb2–/–
phenotype shows similarities to Pierson syndrome, a recently
described human disease resulting from LAMB2 mutations and
characterized by ocular abnormalities, psychomotor defects, and
congenital nephrotic syndrome (10).
The cardinal feature of nephrotic syndrome is severe proteinuria resulting from increased flux of albumin and other plasma
proteins across the GFB. The GBM’s role in glomerular permselectivity, if any, is not clear, and it is now considered secondary to
that of the podocyte slit diaphragm (SD) (11, 12). Nevertheless,
proteinuria can result from either primary podocyte or primary
GBM defects, so how a GBM compositional or structural defect
might cause proteinuria is still debated. Some investigators have
suggested podocyte detachment from the GBM as a possible explanation (13), and this was supported in some kidney injury models
by the presence of viable podocytes in urine (14). However, in the
absence of an acute, severe injury, it is rare to find denuded GBM.
Another possibility is that abnormal matrix components signal
anomalously via podocyte cell surface receptors and disrupt podocyte homeostasis, but this has not been addressed in vivo. The last
theory is that the GBM is a major factor in determining glomerular permselectivity by acting as a modified gel through which macromolecules such as albumin pass primarily by diffusion, indepen-
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Figure 1
Immunofluorescence detection of glomerular laminins. Frozen sections
of normal (left) and Lamb2–/– (right) kidneys were stained for laminin
β2 (Lamβ2; A and B), α5 (C and D), α1 (E and F), α2 (G and H), and
α3β3γ2 (LM-332; I and J). Normal GBM contains laminin β2 and α5
(and γ1; data not shown); laminin α5 was decreased in Lamb2–/– GBM.
Normal glomeruli exhibit variable mesangial staining for laminin α1 and
α2 but not LM-332; however, all were detected ectopically in Lamb2–/–
GBM. Original magnification, ×600.

Here we investigated the compositional, structural, and functional changes in the GBM of Lamb2–/– mice and the pathophysiological consequences. This study was aided by the development
of separate transgene-mediated rescues of the neuromuscular and
glomerular components of the failure-to-thrive phenotype (9).
Lamb2–/– mice carrying a muscle-specific β2 transgene gain weight
normally and only exhibit the glomerular defect. Thus, our analyses of the GFB in older nephrotic mice are not subject to potentially confounding extrarenal defects. Using the electron-dense
tracer ferritin, we were able to test the gel permeation hypothesis
and identify mechanistic differences in permselectivity defects
between the Lamb2–/– (GBM defect) and CD2-associated protein–
null (Cd2ap–/–) (podocyte defect) models of nephrotic syndrome.
Our results show that the GBM has intrinsic and mutable barrier
properties in response to ferritin in vivo, independent of FP architecture, and we conclude that the same is likely true for albumin.

dent of fluid flow (the gel permeation/diffusion hypothesis; ref.
15). In this model, an increased protein concentration in the glomerular ultrafiltrate can result from either of 2 mechanisms: (a)
an alteration in the composition of the GBM, as occurs in Pierson
syndrome and Alport syndrome (16, 17); or (b) a reduction in the
rate of fluid flow across the GFB, as is proposed to occur in cases
of FP effacement due to reduced filtration slit frequency, without
change in the rate of protein diffusion (15).
Tubules also play an important role in proteinuria, as the concentration of protein in the final urine is determined not only by
the GFB but also by tubular reabsorption of filtered protein. Previous work using isolated proximal tubules suggests that albumin
uptake is biphasic; there is a high-affinity/low-capacity pathway
that is saturable at physiologic albumin concentrations and a lowaffinity/high-capacity pathway associated with bulk fluid uptake
(18). This underscores the importance of albumin concentration
in the glomerular filtrate rather than the absolute amount, a concept invoked by the gel permeation/diffusion hypothesis (15).

Results
Lamb2–/– mice exhibit a failure-to-thrive phenotype with severe
neuromuscular weakness and congenital nephrotic syndrome
(7, 8), features consistent with human Pierson syndrome (10). In
order to study these defects independently, we generated transgenic mice expressing rat laminin β2 either in muscle (using the
muscle creatine kinase promoter; MCK-B2 transgene) or in podocytes (using the nephrin promoter; NEPH-B2 transgene). When
bred onto the Lamb2–/– background, MCK-B2 rescues the neuromuscular junction defects, and NEPH-B2 prevents nephrotic
syndrome (9). Although rescue of muscle has no effect on proteinuria, Lamb2–/–MCK-B2 mice are overall much healthier than
Lamb2–/– mice. Nevertheless, Lamb2–/–MCK-B2 mice die at 1
month of age from nephrotic syndrome (9) with elevated blood
urea nitrogen levels (data not shown). Here, we took advantage of
the improved health and weight gain of Lamb2–/–MCK-B2 mice to
study the isolated GFB defect in more detail.
GBM composition and podocyte laminin receptors. During glomerular
maturation, a developmental shift in the laminin components of
the GBM occurs, from LM-111 to LM-511 to LM-521 (19). In the
absence of laminin β2, laminin β1 persists in the GBM (8). Similarly, in Alport syndrome there is reexpression of fetal laminins α1
and β1 (16, 20), suggesting the possible existence of a compensatory response to abnormal GBM. We further investigated GBM
laminin content in Lamb2–/– mice. Laminin α5 was present in the
GBM regardless of whether laminin β2 was present, but levels were
reduced in Lamb2–/– GBM (Figure 1, A–D). In normal kidneys the
GBM lacked laminin α1 and α2 and LM-332 (Figure 1, E, G, and I),
whereas Lamb2–/– GBM exhibited linear staining for all these laminins (Figure 1, F, H, and J). Together with the presence of proteinuria, these results suggest that ectopic laminins are not sufficient to
restore GFB function, and their deposition in the GBM may even be
pathogenic, as proposed for ectopic laminins in Alport syndrome
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Figure 2
Immunofluorescence detection of podocyte proteins. Frozen sections of normal (left) and Lamb2–/– (right) kidneys at P7 and P28 were
stained for integrin α3 (Intα3; A–D), nephrin (E–H), and podocin (I–L).
There were no detectable changes in intensity or distribution of these
proteins in young mice. However, with age and disease progression,
there was a reduction in intensity; all 3 seemed to lose their normal linear distribution and showed a more diffuse granular pattern. This likely
reflects the retraction of FPs and reduced SD density. Magnification,
P7, ×200; P28, ×600.

(16, 17, 20). We also investigated podocyte laminin receptor expression, which is represented primarily by integrin α3β1. Antibody
staining for integrin α3 revealed normal distribution and intensity
early in the disease process (P7; Figure 2, A and B). In contrast, in
older mice (2–4 weeks), there were subtle but clear differences in
intensity and distribution. Integrin α3 staining was less intense
and lost its typical linear localization (Figure 2, C and D), in parallel to the progressive nephrotic syndrome and FP effacement. In
contrast, no changes were detected in integrin α6, integrin α8, or
α-dystroglycan localization or expression (data not shown).
Expression of SD components. Currently, the most favored views
of the GFB propose the podocyte SD as the predominant determinant, with proteinuria and nephrotic syndrome ensuing upon
2274

loss or alteration of SD components or associated proteins (21,
22). We therefore considered the possibility that alterations in the
Lamb2–/– GBM caused proteinuria indirectly by altering expression
or localization of SD components. However, despite congenital
albuminuria in Lamb2–/– mice (Figure 3A), nephrin (Figure 2, E
and F) and podocin (Figure 2, I and J) showed normal distribution and intensity until P14. It was not until after approximately
P21 that we were able to detect significant changes in nephrin and
podocin levels and distribution (Figure 2, G, H, K, and L), which
were comparable to the changes in integrin α3 and likely reflected the widespread FP effacement (9). In addition, we previously
reported that CD2AP exhibits an abnormal granular distribution
in P21 Lamb2–/– podocytes, whereas distribution at P9 was normal
(23). These observations suggest that changes in integrin and SD
components are unlikely to be the primary cause of proteinuria,
but they rather represent secondary changes related to progression
of disease caused by the primary GBM defect.
Glomerular features. To further investigate the temporal relationship between podocyte FP effacement and proteinuria, we
followed these events chronologically. Increased urinary albumin excretion was detected by SDS-PAGE in Lamb2–/– mice as
early as P2 (Figure 3, A and D). Kidneys from the same animals
were viewed using scanning electron microscopy (SEM). Despite
increased albumin excretion, there was no detectable FP effacement (Figure 3, B, C, E, and F). The most distinctive change was
mild podocyte cell body villous transformation (Figure 3 and
Supplemental Figure 1; supplemental material available online
with this article; doi:10.1172/JCI28414DS1), which was detected
previously in experimental nephrotic diseases (24). Transmission
electron microscopy (TEM) confirmed the presence of normalappearing SDs and the absence of FP effacement at early ages
(Supplemental Figure 2). Segmental podocyte FP effacement was
evident at approximately P10 (Figure 3, H and I), whereas the
GBM itself generally appeared normal even near the time of death
(9), except for occasional, mild, segmental irregularities.
Negative charge characteristics. Although laminins are not considered to be highly charged, they do provide the scaffold for incorporation of BM components that impart anionic charge, such as
the sulfated proteoglycans perlecan and agrin. GBM anionic sites
revealed by polyethylenimine labeling are normally distributed at
regular intervals juxtaposed to podocytes and endothelial cells,
but they are sparse in the middle of the GBM (the lamina densa)
(25). Charge density on the podocyte aspect is relatively constant
throughout life, but charges at the endothelial aspect decrease
with age, and in mice they reach a stable number and distribution
at 3–4 weeks. Previously it was shown that negative charge distribution and number correlated well with GBM abnormalities in
diabetic rats and was disorganized in proteinuric diseases (26). In
newborn Lamb2–/– mice, the number of anionic sites at the podo-
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Figure 3
Relationship between proteinuria and FP effacement in Lamb2–/–
glomeruli. (A, D, and G) Equal volumes of urine from normal (left
lanes) and Lamb2–/– (right lanes) littermates at P2, P5, and P10
(respectively) were analyzed by SDS-PAGE. Corresponding kidneys
from normal (B, E, and H) and Lamb2–/– (C, F, and I) mice were analyzed by SEM. At P2 (B and C) and P5 (E and F), there were no signs
of FP effacement, whereas areas of effacement were evident at P10
(H and I). Scale bar in I: 3 μm.

smaller and irregularly spaced as compared with those in littermate controls, especially in older mice. Thus, the lack of laminin
β2 results in disorganization of anionic charges. In the absence of
specific methods for probing GBM organization, we propose that
these data reflect an overall disorganization of GBM architecture.
Ferritin permeability. To test the consequences of altered GBM
composition and organization in Lamb2–/– mice, we used native
ferritin as a tracer. Ferritin is a large, 480-kDa protein with an
iron core containing up to 2,500 iron atoms, making it electron
dense. It has been used since the early 1960s to study glomerular permselectivity (27). Ferritin was injected intravenously into
control/Lamb2–/– littermate pairs at P11–P23 and visualized by
TEM. There was a substantial increase in the number of ferritin
particles in Lamb2–/– versus control GBM as early as 5 minutes
after injection (data not shown), and this persisted at later time
points. Multiple experiments comparing littermates at 1 (Figure 5A and Supplemental Figure 3) and 2 hours (Figure 5, B–D,

cyte aspect of the GBM was mildly reduced (Figure 4A), and in
general they were less regularly distributed compared with those in
control or non-nephrotic Lamb2–/–NEPH-B2 mice. There was also
a slight trend toward more anionic sites in the Lamb2–/– lamina
densa (Figure 4A). After P14 there was a great increase in the number of anionic sites in the lamina densa, and the mild reduction
at the podocyte aspect persisted with age (Figure 4, B–D). Besides
these quantitative differences, Lamb2–/– charged sites tended to be

Figure 4
GBM anionic charge distribution. Anionic sites were localized in
normal and Lamb2–/– glomeruli (as indicated) at birth (A) and after
2 weeks of age (B–D) using polyethylenimine. Anionic sites were
counted and expressed as the number of sites/micrometer of GBM
length in either the lamina densa (LD; middle of the GBM) or the
lamina rara externa (LRE; podocyte aspect). There was a slight but
consistent reduction in the total number of LRE anionic sites in the
Lamb2–/– GBM, but an increase in the number of LD anionic sites at
later ages, consistent with GBM disorganization. Data shown in A
and B are mean ± SD. Scale bars: 125 nm.
The Journal of Clinical Investigation    http://www.jci.org    Volume 116    Number 8    August 2006
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(~70% of control) subepithelial particles in Cd2ap–/– GBM, even in areas
with extensive FP effacement (Figure 6 and Supplemental Figures 5
and 6). Together, these ferritin studies in 2 distinct models of nephrotic
syndrome reveal a clear difference
in intrinsic GBM permeability that
depends upon and is consistent with
the nature of the primary defect.
Discussion
Nephrotic syndrome describes a
heterogeneous group of kidney
diseases characterized by increased
urinary protein (especially albumin), edema, hypoalbuminemia,
hyperlipidemia, and lipiduria.
Although the definition is clear,
and disruption of the GFB is a
shared feature, the etiology and
rate of progression to renal failure varies. Extensive studies over
the last 50 years have attempted
to define the role of each of the
3 layers that constitute the GFB
Figure 5
–/–
Increased GBM permeability to ferritin in Lamb2 mice. Ferritin was detected in the GBM either 1 (A) or in mediating permselectivity, yet
2 (B) hour after a single intravenous injection into control/mutant littermate pairs, at the indicated ages. controversy still exists. Initially the
Ferritin particles were counted in the total surface area of the GBM (expressed as number of ferritin GBM was viewed as the predomiparticles/10,000 nm2) or only at the subepithelial (podocyte) aspect (expressed as number of ferritin nant factor, but recent investigaparticles/μm of GBM length). There was an increase in total and in subepithelial ferritin at 1 hour in all tions have revealed strong, direct
Lamb2–/– mice compared with control or non-nephrotic, rescued Lamb2–/– mice carrying the NEPH-B2 links between proteinuric disorders
transgene (Res). The increase was more remarkable after 2 hours in the older mice. (C–F) Represenof both genetic and idiopathic oritative electron micrographs showing ferritin particles in the GBM of normal (C and D) and Lamb2–/– (E
and F) mice at P11. Note the increased ferritin in the mutant GBM despite the normal FP architecture. gins to podocytes and the SD (21,
22, 30, 31).
D and F are higher magnifications of C and E, respectively. Scale bars: 125 nm.
The availability of animal models provides powerful tools for
and Supplemental Figure 4) after injection consistently showed attempting to distinguish the role of the GBM and SD. Here
increased ferritin levels in the mutant GBM. The difference was we have used Lamb2–/– and Cd2ap–/– mice, 2 distinct models of
even greater for subepithelial ferritin particles (Figure 5, A and B, nephrotic syndrome, to better understand the nature of the GFB.
and Supplemental Figures 3 and 4). Importantly, the presence or By both following the progression of proteinuria with respect to
absence of FP effacement did not significantly affect GBM ferritin the timing of podocyte FP effacement and quantitating the entry
permeability. Furthermore, ferritin permeability in non-nephrotic of an electron-dense tracer molecule into the GFB, we have found
Lamb2–/– mice carrying the NEPH-B2 transgene was normal (Fig- strong evidence that the GBM serves as a major barrier to plasma
ure 5, A and B), providing additional evidence that expression of protein that acts independently of the overlying podocyte. Despite
laminin β2 solely by podocytes is sufficient for a normal GFB. ferritin’s large size compared with albumin (480 versus 67 kDa),
Although there was some variability among experiments, this did previous localization of albumin in normal rat glomeruli by Ryan
not alter the overall conclusion; total ferritin numbers were 1.7- and Karnovsky (32) showed a pattern with striking similarity to
to 5.2-fold higher in Lamb2–/– GBM, and the subepithelial ferritin that of ferritin in our normal mice.
was 1.7- to 13.7-fold higher. Thus, the primary GBM defect
Proteinuria in Lamb2–/– mice stems from a primary GBM defect.
increased the permeability of the GBM to ferritin independent of Laminin β2 is part of LM-521, the predominant laminin in mature
detectable podocyte defects.
GBM. In the absence of laminin β2, and despite compensation by
To assay ferritin permeability in mice with proteinuria due to a other laminins, the GBM is abnormally organized, as shown by
primary podocyte defect, we used Cd2ap–/– mice. These mutants aberrant localization of anionic sites. The abnormal organization
develop proteinuria during the first 10 days of life and eventually could arise in part from the deposition of multiple ectopic lamidie with nephrotic syndrome and extensive glomerular fibrosis at nins (LM-511, -111, -211, and -332) that are not normally found in
7–13 weeks, but GBM composition appears normal (28, 29). GBM the GBM but whose presence is expected to change the usual gel
ferritin distribution was surprisingly different from that observed properties and overall porosity of the GBM (26). This could lead
in Lamb2–/– mice: (a) the total number of GBM ferritin particles was to the observed increased permeability and exposure of podocytes
unchanged from control; and (b) there was a trend toward fewer to atypical hemodynamic forces.
2276
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Figure 6
Normal GBM permeability to ferritin in Cd2ap–/–
mice. Ferritin injections were performed in
Cd2ap–/– and control littermate mice. (A and B)
Total numbers of ferritin particles in the GBM
at 1 and 2 hours after injection were similar in
nephrotic Cd2ap–/– mice and their normal littermates at P21. However, subepithelial ferritin particle numbers were lower in the mutant, despite
the albuminuria. (C–F) Representative electron
micrographs showing ferritin particles in the
GBM of P21 normal (C and D) and Cd2ap–/– (E
and F) mice. D and F are higher magnifications
of C and E, respectively. Scale bars: 125 nm.

We also examined podocyte architecture early during disease
course and defined its relationship to proteinuria. During the
first week of life, proteinuric Lamb2–/– mice had apparently normal
FPs and SDs, and it was not until the second week that there was
gradual FP effacement and loss of SDs. Thus, increased urinary
protein clearly preceded detectable podocyte FP and SD changes.
Proteinuria in the absence of widespread FP effacement indicates
that the SD, which appears intact in young Lamb2–/– mice, is not
a wholly effective barrier to albumin, a conclusion also reached
in rat studies (33). However, here we cannot rule out the possibility that the observed SDs are defective. We note that we are not
the first to report the existence of proteinuria in the absence of
FP effacement; it has also been observed in preeclampsia, in other
animal models, and in sporadic human cases (34–38).
In contrast to our findings in Lamb2–/– mice, entry of ferritin into
the GBM was near normal in heavily proteinuric Cd2ap–/– mice,
which have a primary podocyte defect and a compositionally normal GBM (28, 29). This shows that not all nephrotic mice exhibit
GBM ferritin permeability changes, and it provides further support for the notion that the GBM is the primary sieve and acts as a
modified gel, in accord with the gel permeation/diffusion hypothesis (15). This hypothesis introduced the idea that the mechanism
of proteinuria varies depending on the site of the primary defect
(GBM or podocyte). The hypothesis predicts that only slightly fewer
macromolecules will cross the normal GBM in the presence of FP
effacement, but the accompanying reduced hydraulic permeability
(12, 39) of the GFB (i.e., reduced single-nephron GFR) will lead to
a decreased dilution factor and a greatly increased concentration
of macromolecules in the glomerular filtrate. This is in contrast
to an abnormal GBM, where there is a simple increased flux of
macromolecules. In both cases, the proximal tubule’s protein reab-

sorption machinery would then be unable to
handle this increased concentration, resulting
in proteinuria (15).
So what causes the eventual FP effacement
in Lamb2–/– mice? In vitro studies suggest
that albumin and IgG at plasma concentrations stimulate changes in the podocyte cytoskeleton that could cause or be indicative of
podocyte damage (40). Although in culture
the exposure affects the apical surface, multiple observations have suggested that podocytes can exhibit high endocytic activity at
the basolateral surface in vivo, especially
in nephrotic conditions (27, 41–44). Thus,
there may be a tremendous advantage to sheltering podocytes
from high plasma protein concentrations, which in turn underscores the central importance of the GBM in serving as the major
component of the GFB.
One important outcome of these studies is that we have been able
to show in situ that the GFB is differentially affected in 2 genetically defined proteinuric diseases, reinforcing the notion that
high-level proteinuria can reflect different mechanistic paths. It is
also notable that nephrin, podocin, CD2AP, and integrin α3 were
localized normally until the second week despite the proteinuria
in Lamb2–/– mice, consistent with normal podocyte architecture,
but eventually their intensity and distribution changed markedly.
Given that these abnormalities are far removed from the primary
insult that causes proteinuria (i.e., lack of laminin β2), caution
should be used in drawing conclusions from similar analysis of
human biopsy samples, as they are invariably taken late during
the course of disease.
Methods
Animal models. Lamb2–/– mice and podocyte- and muscle-specific transgenic
rescue of Lamb2–/– phenotypes have been described (7–9), as have Cd2ap–/–
mice (28). Lamb2–/–MCK-B2 (muscle-rescued) mice were used as mutants
for most experiments; in a few cases, Lamb2–/– mice younger than P12
without the transgene were used. For simplicity, all mutants are designated Lamb2–/–, indicating glomerular genotype. Control/mutant pairs were
taken from the same litter. All procedures and experiments were approved
by the Washington University Animal Studies Committee.
Urinalysis. Equal volumes of urine (15 μl) were analyzed on precast 4–20%
SDS polyacrylamide gels (Invitrogen), which were stained with Coomassie
blue. For quantitation, protein and creatinine concentrations were measured with a Cobas Mira plus analyzer (Roche Diagnostics).
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Light and electron microscopy. Kidneys were fixed in 10% buffered formalin,
embedded in paraffin, sectioned, and stained with H&E and PAS by standard methods. For TEM, tissues were fixed, embedded in plastic, sectioned,
and stained as previously described (8). For SEM, small pieces (approximately 2-mm cubes) of kidney cortex were fixed in 3% phosphate-buffered
glutaraldehyde and postfixed in 1% phosphate-buffered osmium tetroxide.
Samples were dehydrated in graded ethanols and critical-point dried in
carbon dioxide. The cubes were then cracked into pieces by stressing with
the edge of a razor blade and mounted with glue onto stubs. The surface
was sputter-coated using gold/palladium and visualized by SEM.
Antibodies and immunofluorescence. Rabbit anti-mouse laminin α5 serum
was described previously (45). Rat anti-mouse laminin α2 mAb 4H8-2 was
purchased from Alexis Biochemicals (Axxora). Other primary antibodies
were gifts from generous colleagues: rabbit anti-mouse laminin β2 (46)
from Takako Sasaki and Rupert Timpl, Max Planck Institute for Biochemistry, Martinsried, Germany; rat anti-mouse laminin α1 mAb 8B3
(47) from Dale Abrahamson, University of Kansas Medical Center, Kansas City, Kansas, USA; rabbit anti-human laminin-332 (α3β3γ2) (48) from
Peter Marinkovich, Stanford University, Stanford, California, USA; rabbit
anti-chick integrin α3 (49) from Mike Dipersio, Albany Medical College,
Albany, New York, USA; rabbit anti-mouse nephrin (50) from Lawrence
Holzman, University of Michigan, Ann Arbor, Michigan, USA; rabbit
anti-human podocin (51) from Corinne Antignac, Necker Hospital, Paris.
Alexa 488- and Cy3-conjugated secondary antibodies were purchased from
Invitrogen and Chemicon International, respectively. Immunofluorescence
analysis was performed as previously described (9).
Negative charge detection. Using a method modified from ref. 52, small
kidney cortex pieces were incubated in 0.5% polyethylenimine (1.8 kDa;
Sigma-Aldrich), pH 7.3, for 30 minutes on ice, washed, and fixed in 2.5%
glutaraldehyde containing 2% phosphotungstic acid for 1 hour on ice.
After washing, tissues were postfixed in 1% osmium tetroxide for 2 hours
at 4°C. Samples were then dehydrated and embedded in plastic. Ultrathin
sections were viewed by TEM without staining. Three to 4 glomeruli were
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